Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 19Thoracic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 35Lung Neoplasms 12Neoplasm Metastasis 10Carcinoma, Renal Cell 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Cutaneous 6Breast Neoplasms 6Brain Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Merkel Cell 5Carcinoma, Hepatocellular 5Uveal Melanoma 4Thyroid Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Mycosis Fungoides 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Carcinoma, Basal Cell 4Waldenstrom Macroglobulinemia 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, T-Cell 3

Interventions

Drug Therapy 2pembrolizumab 1motexafin gadolinium 1cobimetinib 1cabozantinib 1Vemurafenib 1Specimen Handling 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Doxorubicin 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Magnetic Resonance Spectroscopy × Dermatologic × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡